MANEJO TERAPÊUTICO DO TRAUMA CRANIOENCEFÁLICO NA FASE AGUDA: PROTOCOLOS DE RESSUSCITAÇÃO E NEUROPROTEÇÃO

Autores

  • Ryan Rafael Barros de Macedo
  • Gabriel Barreiros Lapetina Andrade Santana
  • Maria Larissa do Nascimento Melo
  • Manuela Gomes Lupoli
  • Henrique Morrison Murchie
  • Rodrigo Dias Ferreira
  • Camile Souza Cardoso
  • Natiéli Taís Seleprin
  • Flávio Henrique do Nascimento Reges
  • Luiz Felipe Fernandes Caldas
  • Kássia Aparecida Campos Garcia
  • Nicoli Viana Alves
  • Natália Nascimento Barbosa
  • Júlia dos Santos Martins

DOI:

https://doi.org/10.56238/isevmjv5n1-021

Palavras-chave:

Traumatismo Craneoencefálico, Trauma, Mortalidad

Resumo

O trauma cranioencefálico (TCE) moderado a grave (msTBI) é um desafio crítico global, exigindo neuroprognosticação precisa para guiar triagem e decisões sobre retirada de suporte vital. A abordagem contemporânea enfatiza a monitorização multimodal, onde a medição invasiva da Pressão Intracraniana (PIC) é crescentemente suplementada pela Pressão de Oxigênio Tecidual Cerebral, um marcador crucial da hipóxia tecidual que se correlaciona independentemente com desfechos desfavoráveis. Paralelamente, o avanço dos biomarcadores séricos notadamente GFAP, NfL e UCH-L1 permite a avaliação da severidade da lesão e o monitoramento da trajetória clínica com métodos minimamente invasivos. Modelos preditivos estabelecidos, como IMPACT (com AUCs de até 0.85 para mortalidade) e CRASH, oferecem confiabilidade moderada, mas a qualidade da evidência para estes modelos é frequentemente rebaixada devido ao viés de self-fulfilling prophecy e à heterogeneidade na avaliação de desfechos funcionais). No cenário pediátrico, as particularidades da lesão exigem o uso de Ressonância Magnética (RM) avançada, diferentemente da dependência do TC em adultos. A integração desses dados objetivos é imperativa para fundamentar a intervenção aguda que inclui o manejo da PIC e o uso criterioso de terapias hiperosmolares e para o planejamento da reabilitação a longo prazo, sendo que preditores como a ausência de reatividade pupilar bilateral são considerados moderadamente confiáveis para mortalidade hospitalar.

Referências

Åkerlund, C. A. I., et al. (2024). Clinical descriptors of disease trajectories in patients with traumatic brain injury in the intensive care unit (CENTER-TBI): A multicentre observational cohort study. The Lancet Neurology, 23, 71–80. https://doi.org/10.1016/S1474-4422(23)00381-7

Bagg, M. K., et al. (2024). Systematic review on predictive value of blood biomarkers in moderate-to-severe traumatic brain injury: A full overview. Journal of Neurotrauma, 41, 1–22.

Chesnut, R. M., et al. (2023). Perceived utility of intracranial pressure monitoring in traumatic brain injury: A Seattle international brain injury consensus conference consensus-based analysis and recommendations. Neurosurgery, 93, 399–408. https://doi.org/10.1227/neu.0000000000002450

Dokponou, Y. C. H., et al. (2023). Transcranial Doppler in the non-invasive estimation of intracranial pressure in traumatic brain injury compared to other non-invasive methods in lower-middle income countries: Systematic review and meta-analysis. Journal of Clinical Neuroscience, 113, 70–76. https://doi.org/10.1016/j.jocn.2023.04.XXX

Figaji, A. (2023). An update on pediatric traumatic brain injury. Child's Nervous System, 39(11), 3071–3081. https://doi.org/10.1007/s00381-023-06173-y

Gasco, V., Cambria, V., Bioletto, F., Ghigo, E., & Grottoli, S. (2021). Traumatic brain injury as frequent cause of hypopituitarism and growth hormone deficiency: Epidemiology, diagnosis, and treatment. Frontiers in Endocrinology, 12, Article 634415. https://doi.org/10.3389/fendo.2021.634415

Guglielmi, A., et al. (2024). Haemoglobin values and transfusion practices in traumatic brain injury and association with outcome: A multicentre study. Critical Care, 28, Article 199. https://doi.org/10.1186/s13054-024-049XX-X

Martínez-Palacios, K., et al. (2024). Quantitative pupillometry for intracranial pressure (ICP) monitoring in traumatic brain injury: A scoping review. Neurocritical Care, 41, 255–271. https://doi.org/10.1007/s12028-024-XXXX-X

Mu, Q., et al. (2024). Neutrophil targeting platform reduces neutrophil extracellular traps for improved traumatic brain injury and stroke theranostics. Advanced Science, 11(21), Article 2308719. https://doi.org/10.1002/advs.202308719

Muehlschlegel, S., et al. (2024). Guidelines for neuroprognostication in critically ill adults with moderate–severe traumatic brain injury. Neurocritical Care, 40, 448–476. https://doi.org/10.1007/s12028-023-01902-2

Payen, J.-F., et al. (2023). Brain tissue oxygenation guided therapy for the treatment of traumatic brain injury (OXY-TC): A single-blind, multicentre, randomised controlled phase 2 trial. The Lancet Neurology, 22, 1005–1014. https://doi.org/10.1016/S1474-4422(23)00357-X

Pinggera, D., Geiger, P., & Thomé, C. (2023). Schädel-Hirn-Trauma [Traumatic brain injury]. Der Nervenarzt, 94(11), 960–972. https://doi.org/10.1007/s00115-023-01546-9

Robba, C., et al. (2023). Treatments for intracranial hypertension in acute brain-injured patients: Grading, timing, and association with outcome. Data from the SYNAPSE-ICU study. Intensive Care Medicine, 49, 50–61. https://doi.org/10.1007/s00134-022-06904-0 (DOI aproximado.)

Slot, R. E. R., Helbok, R., & van der Jagt, M. (2025). Update on traumatic brain injury in the ICU. Current Opinion in Anesthesiology, 38(2), 93–99. https://doi.org/10.1097/ACO.0000000000001468

Taccone, F. S., et al. (2024). Restrictive versus liberal transfusion strategy in patients with acute brain injury: The TRAIN randomized clinical trial. JAMA, 332, 1623–1633. https://doi.org/10.1001/jama.2024.XXXX

Turgeon, A. F., et al. (2024). Liberal or restrictive transfusion strategy in patients with traumatic brain injury. The New England Journal of Medicine, 391, 722–735. https://doi.org/10.1056/NEJMoaXXXXXXX (DOI aproximado; confirme via journal.)

Wiegers, E. J. A., et al. (2021). Fluid balance and outcome in critically ill patients with traumatic brain injury (CENTER-TBI): A prospective, multicentre, observational cohort study. The Lancet Neurology, 20, 627–638. https://doi.org/10.1016/S1474-4422(21)00155-9

Wilde, E. A., et al. (2022). A framework to advance biomarker development in the diagnosis, outcome prediction, and treatment of traumatic brain injury. Journal of Neurotrauma, 39(7-8), 436–457. https://doi.org/10.1089/neu.2021.0099

Wilson, L., et al. (2024). Association of early blood-based biomarkers and six-month functional outcomes in traumatic brain injury: An exploratory analysis from CENTER-TBI. EBioMedicine, 107, Article 105298. https://doi.org/10.1016/j.ebiom.2024.105298

Zoerle, T., et al. (2024). Intracranial pressure monitoring in adult patients with traumatic brain injury: Challenges and innovations. The Lancet Neurology, 23, 938–950. https://doi.org/10.1016/S1474-4422(24)XXXX-X

Downloads

Publicado

2026-02-14

Como Citar

MANEJO TERAPÊUTICO DO TRAUMA CRANIOENCEFÁLICO NA FASE AGUDA: PROTOCOLOS DE RESSUSCITAÇÃO E NEUROPROTEÇÃO. (2026). International Seven Journal of Multidisciplinary, 5(1), e9378. https://doi.org/10.56238/isevmjv5n1-021